Controlling of genotoxic impurities in pharmaceuticals: International harmonisation of regulatory requirements

被引：0

作者：

Kasper, P. ^{[1
]}

机构：

[1] BfArM Bundesinst Arzneimittel & Med Prod, Bonn, Germany

来源：

TOXICOLOGY LETTERS | 2011年 / 205卷

关键词：

D O I：

10.1016/j.toxlet.2011.05.031

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

引用

页码：S7 / S7

页数：1

共 50 条

[1] International harmonisation of regulatory requirements
Holmes, M.
Hill, R. E.
[J]. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2007, 26 (02): : 415 - 420
[2] Evolution of regulatory aspects of genotoxic impurities in pharmaceuticals: Survival of the fittest
Maithani, Mukesh
Raturi, Richa
Gupta, Vikas
Bansal, Parveen
[J]. JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2017, 40 (15) : 759 - 769
[3] International Regulatory Requirements for Genotoxicity Testing for Pharmaceuticals Used in Human Medicine, and Their Impurities and Metabolites
Galloway, Sheila M.
[J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2017, 58 (05) : 296 - 324
[4] Determination of Genotoxic Impurities in Pharmaceuticals
David, Frank
Alegre, Maria Rambla
Vanhoenacker, Gerd
Sandra, Pat
[J]. LC GC EUROPE, 2013, : 31 - 34
[5] Risk assessment of genotoxic impurities in pharmaceuticals
Humfrey, Charles
[J]. TOXICOLOGY LETTERS, 2009, 189 : S39 - S39
[6] Overall impact of the regulatory requirements for genotoxic impurities on the drug development process
Giordani, Antonio
Kobel, Werner
Gally, Hans Ulrich
[J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 43 (1-2) : 1 - 15
[7] Genotoxic impurities in excipients: regulatory implications for International Pharmaceutical Excipients Council
Mroz, C.
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A78 - A79
[8] Advances on genotoxic impurities of sulfonate esters in pharmaceuticals
Liu Xuewei
Li Cheng
Han Haiyun
Zhang Wenpeng
Chen Dongying
[J]. CHINESE JOURNAL OF CHROMATOGRAPHY, 2018, 36 (10) : 952 - 961
[9] Risk assessment and management of genotoxic impurities in pharmaceuticals
Masamitsu Honma
[J]. 中国药理学与毒理学杂志, 2013, (03) : 575 - 575
[10] The EMEA/CPMP initiative on genotoxic impurities in pharmaceuticals
Mueller, L
[J]. MUTAGENESIS, 2004, 19 (06) : 508 - 508

← 1 2 3 4 5 →